In English | En español
Questions About Cancer? 1-800-4-CANCER

Featured Clinical Trials

Highlighted NCI-Supported Cancer Studies < Back to Main

Page Options

  • Print This Page
  • Email This Document

Search Featured Trials

Related Pages

Multiple Cancer Types - Featured Clinical Trials


Targeted Treatment for Advanced Solid Tumors
(Posted: 12/16/2008) - This clinical trial combines the drug dasatinib with the angiogenesis inhibitor bevacizumab for patients with metastatic or unresectable solid tumors.

Batracylin for Patients with Advanced Solid Tumors or Lymphoma
(Posted: 04/01/2008) - In this phase I trial, patients with solid tumors or lymphomas for which standard therapies do not exist or are of minimum benefit and who are slow acetylators, as determined by a blood test, will be treated with increasing doses of the drug batracylin.

Inhibiting Tumor Angiogenesis in Children
(Posted: 01/22/2008) - In this trial, researchers are testing an angiogenesis inhibitor called cediranib in pediatric patients who have solid tumors (except brain tumors) or acute myeloid leukemia (AML), a type of blood cancer.

Radiation Therapies to Treat Brain Metastases
(Posted: 08/21/2007) - In this clinical trial, doctors are comparing stereotactic radiosurgery alone against stereotactic radiosurgery followed by whole-brain radiotherapy in patients with 1-3 cerebral metastases resulting from cancer elsewhere in the body.

Immunotherapy for Nonresponsive Solid Tumors
(Posted: 07/20/2004, Updated: 07/18/2007) - In this phase I trial, researchers are testing the ability of interleukin-7 (IL-7) to stimulate patients' white blood cells to kill cancer cells in solid tumors that have not responded to standard therapies.

< Previous  1 2 3 4 5  Next >